A importância da prossecução da missão do PRRF
O Dr. Michael Trese partilha a razão pela qual a prossecução da missão da PRRF é tão importante para o futuro das crianças, das famílias e dos futuros doentes.
Defender a Esperança: Apoiar as Famílias e Procurar Curas para as Doenças Pediátricas da Retina
The mission of the Pediatric Retinal Research Foundation (PRRF) is to raise awareness of pediatric retinal diseases, drive research, and support the community of affected individuals and their families.
We aspire to transform lives through cure-focused translational research, and to empower those impacted by rare pediatric retinal diseases to realize their full potential.
A Fundação é orientada por seis valores fundamentais que definem quem somos e como nos esforçamos para causar impacto: Excelência, Inovação, Defesa, Envolvimento, Inclusão e Compaixão. Estes valores moldam as nossas acções e reflectem o nosso compromisso de servir a nossa comunidade com integridade e propósito.
A graduate of University of Detroit High School, Albion College (Economics) and the University of Detroit (JD and MBA combined program), Bob is a CFA charter holder, an attorney and a member of the CFA Society of Detroit. Bob and his wife, Anne, have two great kids, Ellen and Daniel. Bob is recently retired and enjoys skiing, cycling and tennis.
Dr. Trese is an active member of the American Academy of Ophthalmology, American Society of Retina Specialists, Association for Research in Vision and Ophthalmology, and Michigan Society of Eye Physicians and Surgeons. He graduated from Michigan State University with a Doctorate in Osteopathic Medicine and Boston University School of Medicine with a Master of Art’s in Medical Sciences. Additionally, he is the son of PRRF Founder, Dr. Michael Trese, and is passionate about honoring his father’s legacy through his involvement in the Foundation.
Dr. Trese is widely considered the father of modern pediatric vitreoretinal surgery. In a career spanning more than 40 years, he has been credited with significant breakthroughs and has taught many of today’s leading pediatric retina specialists.
In the 1980s, he revolutionized pediatric vitreoretinal surgery with his concept of lens-sparing vitrectomy for the treatment of complex pediatric retinal detachment due to advanced retinopathy of prematurity (ROP). His techniques have also been applied to diseases such as familial exudative vitreoretinopathy, juvenile X-linked retinoschisis and Coats disease. He led the way to the first FDA-approved drug for pharmacologic vitreolysis.
In addition to his achievements as a medical doctor, his impact on families world-wide through the work of the Foundation is significant. He championed early translational research in the quest for cures, was instrumental in bringing to reality the only research lab dedicated solely to pediatric retinal research and provided hope to countless families. We will continue this work in honor of our Founder, friend and colleague.
O Dr. Michael Trese partilha a razão pela qual a prossecução da missão da PRRF é tão importante para o futuro das crianças, das famílias e dos futuros doentes.